SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. A Benefit For Realm Of Caring.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

FEBRUARY 28, 2021

It helps to showcase the 103 countries holding events on this day as well as the thousands of events hosted online worldwide. This year, COVID-19 has dramatically impacted the way events are hosted. Instead of having physical locations, many events have opted to go digital being held online.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. This followed a four year struggle during which the family traveled to Canada to bring back medicinal cannabis to treat his 100 seizures a day. of those aged 16 to 24.

Legalization 52

Legalization Medicine Conditions Patients 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 26, 2022

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. Our promising Phase 3 results lead us to apply for the Innovation Passport. Corine de Boer, M.D., Chief Medical Officer at MAPS PBC.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

Cannabis Law Report

AUGUST 17, 2021

We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. The live webcast can be accessed here and on the investor page of Marinus’ website. Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

SEPTEMBER 22, 2021

The latest rule adoption demonstrates growing acceptance for the plant in its medicinal form. . If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina.

Legalization 111

Legalization Patients Cultivation Legislation 111

CannaTech

FEBRUARY 3, 2020

CannaTech is an international event experience that unites cannabis professionals with breakout industry leaders for an unparalleled opportunity to learn, connect and define what’s next for the global cannabis industry. CBD-derived epilepsy drug Epidiolex is currently available in Swiss pharmacies as a prescription drug.

Events 52

Events Hemp CBD Medicine 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Medical marijuana requires a doctor’s recommendation and provides certain advantages, including lower taxes and access to a broader range of products.

Dispensary 52

Dispensary Patients Environment Conditions 52

The Cannigma

MAY 7, 2021

The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. You’ve had this conversation in the US for over 20 years in some states so it’s not as if suddenly overnight, people have woken up to the discussion of cannabis and cannabis legalization and cannabis access. Music by Desca.

Supply Chain 120

Supply Chain Patients Access Hemp 120

WeedAdvisor

MARCH 29, 2019

While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. The most extensive research involved patients with severe – often untreatable – epilepsy. Given the medicinal properties of CBD, available supplies are being reserved for medical users.

Oil 40

Oil CBD Research and Development Epilepsy 40

CannaMD

SEPTEMBER 15, 2020

Where can you use your medicine and when are you at risk of getting arrested? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Do different states recognize Florida medical cards?

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JULY 15, 2022

The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “It’s very important from our perspective to ensure that the Australian patient gets medicine first. The ABC reported back in 2018.

Medicine 52

Medicine Patients Media Supply Chain 52

The Joint Blog

MARCH 9, 2022

Experts and specialists endorse them to treat extreme epilepsy and chemotherapy side effects. 1- Has Medicinal Properties. Viral clips of weed medicines alleviating seizures were shared generally in online media lately, and research has upheld the adequacy of these medicines. influencing an expected 17.3

Sleep 26

Sleep Treatment Conditions Epilepsy 26

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. in the 19th and early 20th centuries, cannabis was frequently used for medicinal purposes, often prescribed by clinicians. Medicinal cannabis: history, pharmacology, and implications for the acute care setting.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

OCTOBER 24, 2019

rst year of making Cannabis legal for both recreational and medicinal purposes. rst in a series, we cover 32 Caribbean countries who are currently evolving their Cannabis Laws for medicinal, religious, recreational and decriminalisation purposes. ANTIGUA & BARBUDA | Status: Medicinal + Decriminalised. ? Page of7 18.

Law 45

Law Medicine Decriminalization Oil 45

The Cannigma

DECEMBER 22, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. We’ve got our regular segment with Americans for Safe Access. We have autism and epilepsy. They have what they call a herbal medicine. Music by Desca. I won’t do too many spoilers here. We can jump straight to the interview.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Puff Puff Post

NOVEMBER 30, 2018

In fact, the Canadian Veterinary Medical Association has teamed up with a group supporting cannabinoid therapy for animals, the Canadian Association of Veterinary Cannabinoid Medicine. They want to push for access to CBD oil to treat sick animals. With these medicinal properties, does it make CBD then the perfect cannabinoid for pets?

Pets 76

Pets Oil CBD Research and Development 76

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Avoid health, medical, and medicinal market statements and claims.

THC 52

THC CBD Media Food 52

SMPL

MAY 26, 2020

We were talking about, ‘What can we do with this?’ ” recalled Samantha Miller, who hosted the event at her split-level house, wedged between redwoods and a creek below. Alas, Mr. Gardner wrote in 2005, that would require access to expensive testing equipment. At a certain point, it had a life of its own,” Ms.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

JANUARY 27, 2020

The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. Video News Event Campaign All . Inevitably, this is an area we’re watching very closely. Related Content.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

DECEMBER 30, 2019

Now, nearly 1 in 4 Americans reside in a jurisdiction where the adult use of cannabis is legal, and 33 states regulate medical marijuana access. In the existing state-legal regulated marijuana marketplaces, businesses struggle to access basic banking services due to the federal prohibition of marijuana. A Pathway Towards SAFE Banking.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. They don’t want to disallow access to the only thing that may stop epileptic seizures in children or is part of a patient’s treatment plan.”

Law 40

Law Seed-To-Sale Hemp Recreational 40

SpeedWeed

MAY 22, 2021

While nuclear medicine can be helpful when science can’t effectively map neurophysiology without radiopharmaceuticals, it’s best not to blast anyone — or anything — with unnecessary amounts of radioactive material, especially if more effective technology exists. I’m not sure why that is, considering shrooms are by far the most accessible.

Research and Development 52

Research and Development Microdosing Wellness and Beauty Pets 52